Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.9197
Nov 20 • 3:59 PM ET Dollar change+0.0197 Percentage change(2.19%)
Aftermarket Close
0.9197
Aftermarket • 4:15 PM ET Dollar change0.0000 Percentage change(0.00%)
Index
-
Market Cap
48.01M
Enterprise Value
32.21M
Income
-29.64M
Sales
0.87M
Book/sh
1.27
Cash/sh
0.42
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
17
IPO
Mar 27, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
55.18
P/B
0.72
P/C
2.18
P/FCF
-
EV/EBITDA
-
EV/Sales
37.02
Quick Ratio
2.32
Current Ratio
2.35
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-0.58
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
-16.25% 17.01%
Sales past 3/5Y
46.32% 1.73%
EPS Y/Y TTM
43.74%
Sales Y/Y TTM
-4.69%
EPS Q/Q
36.74%
Sales Q/Q
-30.29%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
32.60%
Insider Trans
0.00%
Inst Own
7.78%
Inst Trans
4.18%
ROA
-30.06%
ROE
-36.88%
ROIC
-44.69%
Gross Margin
71.85%
Oper. Margin
-3821.17%
Profit Margin
-3390.73%
SMA20
-13.20%
SMA50
-35.46%
SMA200
-44.85%
Trades
Shs Outstand
51.39M
Shs Float
35.17M
52W High
3.96 -76.78%
52W Low
0.85 8.20%
Volatility
14.13% 11.18%
ATR (14)
0.13
RSI (14)
32.79
Beta
0.78
Rel Volume
1.12
Avg Volume
139.88K
Volume
156,490
Perf Week
-14.05%
Perf Month
-28.15%
Perf Quarter
-58.00%
Perf Half Y
-31.37%
Perf YTD
-22.06%
Perf Year
-25.83%
Perf 3Y
-48.61%
Perf 5Y
-84.76%
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.90
Price
0.92
Change %
2.19%
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the following segments: Healthcare, Infusion Technology, and Real Estate. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The Infusion Technology segment manages equity interest on Day Three. The Real Estate segment refers to the company's real estate holdings. The company was founded in 2017 and is headquartered in Newark, NJ.
CEOMr. Howard S. Jonas
Chief Financial OfficerMr. David A. Polinsky Esq.
Chief Operating OfficerMr. Joshua M. Fine
Corporate SecretaryMs. Joyce J. Mason Esq.